Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C and autoreactivity.

Francesco B Bianchi1, Paolo Muratori, Alessandro Granito

  • 1Department of Internal Medicine, Cardioangiology, Hepatology, Alma Mater Studiorum-University of Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy. francesco.bianchi@unibo.it

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
|December 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Foxp3<sup>+</sup> Tregs in HCC immunity and immunotherapy.

Trends in molecular medicine·2026
Same author

Actin-specific smooth muscle antibodies bridge adult and juvenile autoimmune hepatitis diagnosis.

JHEP reports : innovation in hepatology·2026
Same author

An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final Analysis.

Liver cancer·2026
Same author

Primary biliary cholangitis: current insights and novel therapies.

Expert review of clinical immunology·2026
Same author

Cutting edge reviews: Battling one Neglected Tropical Disease after another.

PLoS neglected tropical diseases·2026
Same author

Letter: Double PBC-Related Autoantibody Positivity-How Essential Is It for Diagnosis?

Alimentary pharmacology & therapeutics·2026
Same journal

Effectiveness and safety of mirikizumab in multirefractory ulcerative colitis: analysis from a real-world cohort.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same journal

Novel approaches to liquid biopsy in pancreatic cancer.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same journal

GLP-1 receptor agonists in pediatric obesity.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same journal

An unusual gastric mass in a patient with human immunodeficiency virus infection.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same journal

Fibrate therapy in primary sclerosing cholangitis: missing data on lipids, interactions, and cancer risk.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same journal

Pharmacovigilance of drug-induced microscopic colitis: time to consider exposure duration and dechallenge completeness.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
See all related articles

Hepatitis C virus (HCV) infection is linked to autoimmune phenomena through molecular mimicry and B cell activation. This review explores these autoimmune aspects in HCV patients, their clinical relevance, and treatment implications.

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) discovery in 1989 prompted research into its role in idiopathic diseases, particularly autoimmune disorders.
  • While some associations remain unconfirmed, immune abnormalities like autoantibodies and cryoglobulins are frequently reported in HCV patients.
  • The link between HCV and autoimmunity is hypothesized via molecular mimicry (HCV proteins mimicking self-proteins) and polyclonal B cell activation.

Purpose of the Study:

  • To review the major autoimmune phenomena observed in patients with Hepatitis C virus infection.
  • To discuss the clinical and therapeutic implications of these autoimmune manifestations.

Main Methods:

  • Literature review focusing on studies investigating autoimmune aspects in HCV-infected individuals.

Related Experiment Videos

  • Analysis of proposed mechanisms linking HCV to autoimmunity, including molecular mimicry and B cell activation.

    • Main Results:

    • HCV infection is associated with various immune abnormalities, including non-organ-specific autoantibodies and cryoglobulins.
    • Molecular mimicry and direct B cell activation by HCV are proposed mechanisms for developing autoimmunity.
    • These autoimmune phenomena have significant clinical and therapeutic relevance in managing HCV patients.

    Conclusions:

    • Autoimmune phenomena are a notable feature in Hepatitis C virus infection.
    • Understanding the mechanisms and clinical impact of autoimmunity in HCV is crucial for patient management and treatment strategies.